Genrui Biotech Inc.

Call Directions Website Contact the business

Genrui Biotech Inc. Our mission is
to provide professional IVD solutions to
customers over the world.

We're delighted to invite our partners, distributors, and customers to visit us at MEDICA 2026 — the world's leading tra...
16/10/2026

We're delighted to invite our partners, distributors, and customers to visit us at MEDICA 2026 — the world's leading trade fair for medical laboratory technology.

📅 16 – 19 November 2026
📍 Messe Düsseldorf, Germany
🏭 Hall 3 · Booth B58

Get an up-close look at our latest innovations:
▪️ PA480 — Fully-auto Specific Protein Analyzer (Nephelometry)
▪️ MT120S — Fully-auto Chemiluminescence Immunoassay Analyzer
▪️ LungeKlar® CLIA — Early Screening & Lung Nodule Risk Stratification

🤝 Whether you'd like to explore partnership opportunities, see live product demos, or simply say hello — our team will be there and happy to meet you.
Let's connect in Düsseldorf! Drop us a message or comment below to arrange a meeting in advance.

October 12 is World Arthritis Day.Arthritis affects millions of people worldwide and can have a lasting impact on everyd...
12/10/2026

October 12 is World Arthritis Day.

Arthritis affects millions of people worldwide and can have a lasting impact on everyday life. Today, let's raise awareness of arthritis and make joint health a shared priority.

Laboratory testing can support the assessment of arthritis-related conditions. Genrui's testing menu features:
• Rheumatic disease-related tests: Anti-CCP, RF and ASO
• Inflammation tests: CRP, IL-6 and SAA
• Immune-related tests: C3, C4, IgG, IgA and IgM

Both the FA Quantitative Immunofluorescence Platform and the PA Specific Protein Analyzer Platform support arthritis-related testing.

Together, let's give joint health the attention it deserves.

September 29 is World Heart Day. Let's pay attention to heart health together!We can take the time to understand our ind...
29/09/2026

September 29 is World Heart Day. Let's pay attention to heart health together!
We can take the time to understand our individual risks, and seek timely medical attention, testing, and care when something doesn't feel right.

In vitro diagnostic testing can help inform cardiovascular assessments and guide follow-up care and treatment decisions.
Genrui's Quantitative Immunofluorescence Platform offers reliable point-of-care testing solutions. Our cardiovascular menu includes cTnI, hs-cTnI, CK-MB, Myo, NT-proBNP, and hs-CRP to support the assessment of myocardial injury, heart failure, and cardiovascular risk.

Care for your heart. Know your heart.

Genrui Biotech is pleased to announce the donation of FA50 Quantitative lmmunoassay Analyzer to the Mongolian Democratic...
24/09/2026

Genrui Biotech is pleased to announce the donation of FA50 Quantitative lmmunoassay Analyzer to the Mongolian Democratic Party Youth Association, in support of expanded access to diagnostic testing for communities across Mongolia.
The FA50 delivers accurate and rapid immunoassay results in point-of-care settings, extending dependable diagnostic capability to primary healthcare facilities where laboratory infrastructure remains limited.
We extend our sincere appreciation to the Youth Association for their partnership and gracious reception. Genrui remains committed to advancing diagnostic excellence worldwide, and to ensuring that reliable testing is within reach of every community we serve.

Multiple Myeloma: Follow the Light ChainsAs one of the most common hematologic malignancies worldwide, multiple myeloma ...
18/09/2026

Multiple Myeloma: Follow the Light Chains

As one of the most common hematologic malignancies worldwide, multiple myeloma (MM) deserves greater attention this Blood Cancer Awareness Month.

Free Kappa (κ), Free Lambda (λ), and the κ/λ ratio provide important insights for MM detection, assessment, and monitoring.

Genrui Free KAP & Free LAM assays on the PA240 & PA480 bring automated FLC testing to your specific protein menu.

Follow the light chains. Detect the clues. Support better care.

17/07/2026

Great news from Peru!

One PA240 Fully Auto Specific Protein Analyzer based on nephelometry technology has been successfully installed at Acapulco Health Center, one of the leading 24-hour public healthcare centers in Peru, supporting a daily workload of around 25–30 samples.

With stable performance, user-friendly operation, and efficient workflow, PA240 continues to demonstrate its value in routine clinical laboratories and public healthcare settings.

We are proud to support our partners in Peru with practical and dependable laboratory solutions.

Genrui's Folate Item is coming！ — Starting with the Folate TestFolate deficiency is silent, common, and clinically conse...
17/07/2026

Genrui's Folate Item is coming！
— Starting with the Folate Test
Folate deficiency is silent, common, and clinically consequential. We've brought it onto the Genrui FA series POCT platform — quantitative, fast, and built for the point of care.

🩸 Diagnosis of folate deficiency — fast, quantitative assessment at the point of care
🩸 Differential diagnosis of megaloblastic anemia — distinguish folate from B12 causes

Proven Performance! Independently Verified!We're proud to announce that selected Specific Protein assays on the Genrui P...
13/07/2026

Proven Performance! Independently Verified!

We're proud to announce that selected Specific Protein assays on the Genrui PA240 & PA480 Fully-auto Specific Protein Analyzers have successfully completed the 2026 External Quality Assessment (EQA) program.

Organized by the National Center for Clinical Laboratories (NCCL), China's national authority for clinical laboratory quality assessment, the NCCL EQA program represents the country's highest level of external quality assessment for clinical laboratories, providing independent verification of testing performance.

The successfully evaluated assay categories include:
✅ Specific Proteins (KAP, LAM, CRP, RF, IgG, etc.)
✅ Urine Protein Markers
✅ Glycated Hemoglobin (HbA1c)

These results further demonstrate the accuracy, consistency, and reliability of Genrui's nephelometry-based specific protein testing solution, giving laboratories greater confidence in their routine testing.

PA240 & PA480
Reliable Quality. Consistent Performance. Trusted Results.

01/07/2026

Great news from Türkiye!

Three PA480 Fully Auto Specific Protein Analyzers based on nephelometry technology have been successfully installed at the largest hospital in Samsun, Türkiye, supporting a daily workload of around 700 tests.

The systems are mainly used for routine specific protein assays and free light chain testing. The hospital is highly satisfied with the reliable results, professional service support, and user-friendly operation of PA480.

With stable performance, efficient workflow, and strong clinical value, PA480 continues to demonstrate its strength in high-volume hospital laboratories.

A big thank you to our trusted partner Farmasina Tıbbi ve Kimyevi Ürünler San Dış Tic Ltd Şti for the excellent collaboration and professional support throughout this project.

We look forward to achieving even more milestones together!

Happy Father’s Day to all the amazing dads who inspire us with their strength, dedication, and care.Behind every achieve...
21/06/2026

Happy Father’s Day to all the amazing dads who inspire us with their strength, dedication, and care.
Behind every achievement, there is often a father’s quiet support and unwavering commitment. Today, we celebrate the fathers who lead with love, create a better future, and make a difference every day.
Wishing all fathers a wonderful Father’s Day filled with appreciation, joy, and precious moments with loved ones.

Address

Guangming
Shenzhen
518000

Telephone

+8675526678255

Website

Alerts

Be the first to know and let us send you an email when Genrui Biotech Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Genrui Biotech Inc.:

Shortcuts

Share

Category